Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

N. U. Tadjieva

7 та иш

Tashkent Medical Academy, Tashkent, Republic of Uzbekistan

  1. Antibiotic use and knowledge in the community of Yemen, Saudi Arabia, and Uzbekistan

    Tatiana Belkina, Abdullah Al Warafi, Elhassan Hussein Eltom Abdalla +3

    МақолаAntibiotic Use and ResistanceThe Journal of Infection in Developing Countries20144 иқтибос
    ABI

  2. Effectiveness of Vaccination against Pneumococcal Infection in Uzbekistan: a Preliminary Assessmant and Prognosis

    T. A. Daminov, L. N. Tuychiev, N. U. Tadjieva +1

    МақолаPneumonia and Respiratory InfectionsCHILDREN INFECTIONS20181 иқтибос
    ABI

  3. PECULIARITIES OF THE PNEUMOCOCCAL PNEUMONIAE IN CHILDREN

    T. A. Daminov, L. N. Tuychiev, N. U. Tadjieva +1

    МақолаPneumonia and Respiratory InfectionsDOAJ (DOAJ: Directory of Open Access Journals)20150 иқтибос
    ABI

  4. A clinical case of coinfection of COVID-19 and tropical malaria

    L. N. Tuychiev, М. Д. Ахмедова, N. U. Tadjieva +4

    МақолаCOVID-19 epidemiological studiesJournal Infectology20230 иқтибос
    ABI

  5. Obtaining and Characterization of Experimental Diagnostic Brucellosis Rabbit Sera for the Development of a National Standard for Brucellosis Serum

    L. N. Tuychiev, B. M. Tadjiev, N. U. Tadjieva +5

    МақолаBrucella: diagnosis, epidemiology, treatmentEpidemiology and Vaccinal Prevention20240 иқтибос
    ABI

  6. Purulent-inflammatory manifestations in the oropharynx in children with infectious mononucleosis

    L. N. Tuychiev, N. U. Tadjieva, G. T. Shermukhamedova +1

    МақолаViral-associated cancers and disordersCHILDREN INFECTIONS20240 иқтибос
    ABI

  7. Technology for Producing Hyperimmune Agglutinating Sera against Salmonella using Various Immunization Schemes and Studying the Biochemical and Immunological Parameters of the Sera

    L. N. Tuychiev, B. M. Tadjiev, N. U. Tadjieva +5

    МақолаSalmonella and Campylobacter epidemiologyEpidemiology and Vaccinal Prevention20250 иқтибос
    ABI